Hofseth BioCare ASA (FRA:HBQ) Net Income From Continuing Operations : €-10.85 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Hofseth BioCare ASA Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Hofseth BioCare ASA's net income from continuing operations for the three months ended in Mar. 2025 was €-2.78 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was €-10.85 Mil.

Hofseth BioCare ASA Net Income From Continuing Operations Historical Data

The historical data trend for Hofseth BioCare ASA's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hofseth BioCare ASA Net Income From Continuing Operations Chart

Hofseth BioCare ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

-9.64

-12.46

-13.13

-9.27

-10.67

Hofseth BioCare ASA Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															-2.52	-1.54	-2.97	-3.56	-2.78

Hofseth BioCare ASA Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-10.85 Mil.

Hofseth BioCare ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hofseth BioCare ASA (FRA:HBQ) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

HOFBF:USA HBCO:Sweden HBC:Norway 0Q6H:UK

Address

Keiser Wilhelms Gate 24, Aalesund, NOR, 6003

Website

https://www.hofsethbiocare.com

Hofseth BioCare ASA is a Norway-based company engaged in the business of developing, manufacturing, marketing, and selling marine ingredients such as oil, calcium, and protein products. Its products and their respective brands include salmon oil (OmeGo), hydrolyzed soluble protein (ProGo), Calcium/Collagen (CalGo or NT-II), and non-soluble protein (PetGo), all of which are produced in the Midsund plant. The firm sells its products to various segments of the human nutrition market, such as sports nutrition, supplements, and health foods, as well as to the market within nutrition for the pet and feed industry. It generates maximum revenue from the sale of salmon oil. Geographically, the company generates maximum revenue from Europe, followed by North America and Asia.

Hofseth BioCare ASA Headlines

No Headlines